Recombinant fusion protein of bacterial beta-galactosidase and EBV LMP-1
Conjugate
Unconjugated
Target
Alternative Names
Latent membrane protein 1; EBV;Epstein Barr virus; HHV4; Human Herpesvirus 4; LMP1; LMP; Protein p25;Protein p63; Herpesviridae; Gammaherpesvirinae; Lymphocryptovirus; Humanherpesvirus 4 (HHV-4)
Product Background
Antigen Description
Latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) is a transforming protein that affects multiple cell signalling pathways and contributes to EBV-associated oncogenesis. LMP1 can be expressed in some states of EBV latency, and significant induction of full-length LMP1 is also observed frequently during virus reactivation into the lytic cycle. LMP1 is critical for EBV-infected cell activation, adhesion and survival, and is usually expressed in the malignant cells.
Citations
Publication ()
Have you cited DMAB3329 in a publication? Let us know and earn a reward for your research.
Q: What is the formulation of the buffer used in Anti-EBV LMP Antibody?
A: The formulation of the buffer used in Anti-EBV LMP Antibody is 0.01 M PBS, pH 7.2. The product does not contain any stabilizing proteins.
Customer Reviews
My Review for Anti-EBV Latent Membrane Protein Monoclonal antibody, Clone Mixed1
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
